Joshua Pinto - Aug 22, 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Signature
/s/ Joshua Pinto
Stock symbol
NMRA
Transactions as of
Aug 22, 2024
Transactions value $
-$984,061
Form type
4
Date filed
8/26/2024, 06:17 PM
Previous filing
Jun 28, 2024
Next filing
Aug 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Sale -$331K -28.5K -11.92% $11.63 210K Aug 22, 2024 See footnote F1, F2, F3
transaction NMRA Common Stock Sale -$280K -24.2K -11.48% $11.59 186K Aug 23, 2024 See footnote F1, F3, F4
transaction NMRA Common Stock Sale -$373K -31.6K -16.98% $11.78 155K Aug 26, 2024 See footnote F1, F3, F5
holding NMRA Common Stock 85K Aug 22, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 18, 2024 and subsequently amended on May 22, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $11.43 to $12.06, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Shares held by Maple DE Holdings LLC.
F4 This transaction was executed in multiple trades at prices ranging from $11.40 to $11.74, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $11.61 to $11.98, inclusive. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.